You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Medtronic
Baxter
McKinsey
Colorcon

Last Updated: September 24, 2023

ADDYI Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Addyi patents expire, and what generic alternatives are available?

Addyi is a drug marketed by Sprout Pharms and is included in one NDA. There are two patents protecting this drug.

This drug has forty-two patent family members in twenty-nine countries.

The generic ingredient in ADDYI is flibanserin. One supplier is listed for this compound. Additional details are available on the flibanserin profile page.

DrugPatentWatch® Generic Entry Outlook for Addyi

Addyi was eligible for patent challenges on August 18, 2019.

Indicators of Generic Entry

< Available with Subscription >

  Try a Trial

Summary for ADDYI
Drug patent expirations by year for ADDYI
Drug Prices for ADDYI

See drug prices for ADDYI

Pharmacology for ADDYI
Mechanism of ActionP-Glycoprotein Inhibitors

US Patents and Regulatory Information for ADDYI

ADDYI is protected by two US patents.

Patents protecting ADDYI

Method of treating female hypoactive sexual desire disorder with flibanserin
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: USE OF FLIBANSERIN OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF TO TREAT HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)

Treating sexual desire disorders with flibanserin
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: USE OF FLIBANSERIN OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF TO TREAT HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ADDYI

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 ⤷  Try a Trial ⤷  Try a Trial
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 ⤷  Try a Trial ⤷  Try a Trial
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ADDYI

See the table below for patents covering ADDYI around the world.

Country Patent Number Title Estimated Expiration
Croatia P20040107 STABILNI POLIMORF FLIBANSERINA, TEHNIČKI POSTUPAK NJEGOVA PRIPRAVLJANJA, TE NJEGOVA PRIMJENA U PROIZVODNJI LIJEKOVA (STABLE POLYMORPH OF FLIBANSERIN, TECHNICAL PROCESS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS) ⤷  Try a Trial
Montenegro P42808 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 03014079 ⤷  Try a Trial
China 102125557 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Express Scripts
McKesson
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.